Chuah, Charles
197  Ergebnisse:
Personensuche X
?
2

CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictiv..:

Apperley, Jane ; Cortes, Jorge ; Jabbour, Elias...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S339 , 2023
 
?
3

CML-313 Post Hoc Analysis of Patient Responses by T315I Mut..:

Cortes, Jorge ; Deininger, Michael ; Lomaia, Elza...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S338 , 2023
 
?
5

CML-310 Early Cytogenetic or Molecular Landmark Response to..:

Müller, Martin C. ; Cortes, Jorge ; Chuah, Charles...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S336-S337 , 2023
 
?
7

POSTER: CML-313 Post Hoc Analysis of Patient Responses by T..:

Cortes, Jorge ; Deininger, Michael ; Lomaia, Elza...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S176 , 2023
 
?
8

POSTER: CML-310 Early Cytogenetic or Molecular Landmark Res..:

Müller, Martin C. ; Cortes, Jorge ; Chuah, Charles...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S175 , 2023
 
?
9

POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is P..:

Apperley, Jane ; Cortes, Jorge ; Jabbour, Elias...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S179 , 2023
 
?
 
?
12

Application of High Throughput Technologies in the Developm..:

Xiang, Wei ; Lam, Yi Hui ; Periyasamy, Giridharan.
International Journal of Molecular Sciences.  23 (2022)  5 - p. 2863 , 2022
 
?
13

CML-046 Dose Modification Dynamics of Ponatinib in Patients..:

Apperley, Jane ; Kantarjian, Hagop ; Deininger, Michael...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S284-S285 , 2022
 
?
 
?
 
1-15